H. Minderman et al., CELL-CYCLE RELATED UPTAKE, RETENTION AND TOXICITY OF IDARUBICIN, DAUNORUBICIN AND DOXORUBICIN, Anticancer research, 13(4), 1993, pp. 1161-1165
Exponentially growing Molt-4 cells were separated by means of counterf
low centrifugation into fractions enriched for cells in early G1, late
G1, S, or G2+M phase of the cell cycle. Subsequently, cells were expo
sed for 2 h to Idarubicin (Ida, 0.02 - 0.15 mug/ml), Daunorubicin (Dnr
, 0.1 - 0.75 mug/ml) or Doxorubicin (Dox, 0.1 - 0.75 mug/ml). Drug upt
ake, measured by flow cytometry, increased progressively with cell cyc
le traverse from early G1-to M-phase. The relative fraction of drug lo
st following an extensive wash procedure was 72% in case of Ida and 23
% for Dnr and Dox and was independent of the cell cycle phase. Inhibit
ion of DNA synthesis was determined by qualitative flow cytometric ana
lysis of 5-iodo-2'-deoxyuridine (IdUrd) incorporation into DNA. The th
ree drugs showed a similar gradual increase of inhibition of DNA synth
esis from G1 to G2+M phase, demonstrating that cell cycle phase depend
ency of drug toxicity applies to all three anthracyclines studied.